Early Phase 1 Interstitial Lung Disease Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who fully understand what the trial involves, including its purpose, methods, and possible side effects, and who are willing to sign a consent form agreeing to take part
• People whose Body Mass Index (BMI) falls between 19 and 26 kg/m², and who weigh at least 50 kg (if male) or at least 45 kg (if female)
• People who the trial doctor considers to be in good overall health
• People who are able to use reliable contraception during the trial and for a period of time after it ends

Who may not be able to join:

• People who have a history of severe allergic reactions to any drug or other substance
• People who have breathing symptoms or any known abnormality of the airways or respiratory tract
• People who currently have a mouth or oral health condition that the trial doctor believes may interfere with using the trial medication or devices
• People who have other illnesses or health factors that show abnormal clinical signs (confirm with trial site)
• People who have a history of drug abuse, or who used recreational or narcotic drugs in the period before screening, or whose urine drug test at the start of the trial comes back positive
• People who smoked more than 5 cigarettes per day in the period before screening
• People who drank more than 14 units of alcohol per week in the period before screening, or whose breath alcohol test at the start of the trial is positive
• People who have had a serious illness or major surgery within a certain period before the trial begins, or who are expected to need major surgery during the trial (confirm with trial site for specific timeframes)
• People who have taken other medications within a certain period before joining the trial (confirm with trial site for specific timeframes)
• People whose lung function test results fall below 80% of the expected normal value for either FEV1 or FVC measurements during screening
• People who test positive for HIV, Hepatitis B, Hepatitis C, or syphilis
• People who have difficulty with blood draws, or who have a history of fainting or extreme fear in response to needles or blood
• Women who test positive for pregnancy during screening or at the trial's start, or who are currently breastfeeding
• People who have taken part in another clinical drug trial and used an investigational drug within a certain period before joining this trial (confirm with trial site for specific timeframes)
• People who have donated blood or lost more than 400 mL of blood in the period before screening
• People whom the trial doctor considers unsuitable for any other reason

Important: Always verify eligibility with the trial site directly before applying.